Search research articles
Contact Us
Filters
Showing results (11-20 of 114) with videos related to
Page
of 12
Sort By:
Seminars in Oncology
|
October 1, 1994
Summary of data from in vitro and phase I vinorelbine (Navelbine) studies
H A Burris, S Fields
The Annals of Pharmacotherapy
|
May 1, 1996
Vinorelbine: a new antineoplastic drug for the treatment of non-small-cell lung cancer
S F Jones, H A Burris
Hematology/Oncology Clinics of North America
|
April 1, 1994
Topoisomerase I inhibitors. An overview of the camptothecin analogs
H A Burris, S M Fields
Advances in Pharmacology (San Diego, Calif.)
|
January 1, 1994
Clinical development of topoisomerase-interactive drugs
F M Muggia, H A Burris
Cancer Practice
|
January 1, 1996
Topoisomerase I inhibitors: topotecan and irinotecan
S F Jones, H A Burris
Seminars in Oncology
|
December 1, 1995
Docetaxel (Taxotere) in combination: a step forward
H A Burris, S Fields, N Peacock
Seminars in Oncology
|
August 7, 1999
Weekly administration of docetaxel (Taxotere): summary of clinical data
J D Hainsworth, H A Burris, F A Greco
Seminars in Oncology
|
August 2, 2001
Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experience
J D Hainsworth, H A Burris, F A Greco
Oncology (Williston Park, N.Y.)
|
August 29, 2000
Gemcitabine, paclitaxel, and carboplatin for advanced non-small-cell lung cancer
F A Greco, H A Burris, J D Hainsworth
Cancer
|
September 15, 1992
Testicular relapse in adult acute myelogenous leukemia
D W Shaffer, H A Burris, T J O'Rourke
Page
of 12
Search research articles
Search
Showing results (11-20 of 114) with videos related to
Sort By:
Page
of 12
Seminars in Oncology
|
October 1, 1994
Summary of data from in vitro and phase I vinorelbine (Navelbine) studies
H A Burris, S Fields
The Annals of Pharmacotherapy
|
May 1, 1996
Vinorelbine: a new antineoplastic drug for the treatment of non-small-cell lung cancer
S F Jones, H A Burris
Hematology/Oncology Clinics of North America
|
April 1, 1994
Topoisomerase I inhibitors. An overview of the camptothecin analogs
H A Burris, S M Fields
Advances in Pharmacology (San Diego, Calif.)
|
January 1, 1994
Clinical development of topoisomerase-interactive drugs
F M Muggia, H A Burris
Cancer Practice
|
January 1, 1996
Topoisomerase I inhibitors: topotecan and irinotecan
S F Jones, H A Burris
Seminars in Oncology
|
December 1, 1995
Docetaxel (Taxotere) in combination: a step forward
H A Burris, S Fields, N Peacock
Seminars in Oncology
|
August 7, 1999
Weekly administration of docetaxel (Taxotere): summary of clinical data
J D Hainsworth, H A Burris, F A Greco
Seminars in Oncology
|
August 2, 2001
Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experience
J D Hainsworth, H A Burris, F A Greco
Oncology (Williston Park, N.Y.)
|
August 29, 2000
Gemcitabine, paclitaxel, and carboplatin for advanced non-small-cell lung cancer
F A Greco, H A Burris, J D Hainsworth
Cancer
|
September 15, 1992
Testicular relapse in adult acute myelogenous leukemia
D W Shaffer, H A Burris, T J O'Rourke
Page
of 12